Description: The industry sees extreme value in predictive modeling and its ability to help us meet customer demands and remain profitable, but do customers and regulators look at this as a favorable addition to our process? Hear from a dynamic panel of industry experts who will tackle a variety of issues and questions from the state of the regulatory environment to the responsibilities of the carrier.

Description: Come discuss inforce management techniques that go beyond the traditional methods of adjusting non-guaranteed elements within contractual limits. Methods such as retention, cross-selling/up-selling, wellness, exchange programs and other customer behavior initiatives will be presented with relevant considerations.

Description: Many insurance companies have started Diversity, Equity, and Inclusion (DEI) initiatives over the past few years to better engage with their employees and communities in new ways. Explore another important audience of DEI programs: the customers who purchase insurance products. Review research on the unique needs of specific groups that may have been underserved by insurance companies in the past. You will also touch on ways to make the insurance buying process more accessible to everyone.

Description: For decades, drug overdose deaths have been increasing within the U.S., with opioid-related mortality driving this increase. The Society of Actuaries Research Institute (SOA) sponsored this research to investigate the trends and drivers behind drug overdose mortality and substance-related deaths as a whole. Findings provided a range of insights surrounding substance use disorder, drug overdose and alcohol-induced mortality, and considerations for insurers.

Description: Fairness in life insurance isn’t a checkbox—it’s a set of choices, trade-offs, and consequences. In this webcast, the report’s author will walk through a practical framework for defining and measuring fairness in life insurance workflows, showing why “fair” can mean very different things depending on whether you’re focusing on individuals or groups—and why you often can’t optimize both at once. You’ll get a clear tour of the major fairness criteria used in today’s literature—what they measure, where they fit in insurance, and what can break when you adopt them . Expect straight talk, concrete insurance-oriented examples, and guidance on selecting metrics that align with business objectives, regulatory expectations, and stakeholder priorities—without pretending there’s a one-size-fits-all answer.

Description: Join us for an exciting session as Actuarial Innovation & Technology Strategic Research from the SOA's Research Institute unveils two recently published research reports: ""Unveiling the Life Insurers' Actuarial Transformation Journey and the Impact of Analytics"" and ""Exploring Revolutionary Advances in Underwriting: An Initial Assessment of Epigenetics, Medical Tests, and Wearables"". In the first report, we delve into the evolving landscape of life insurers' Actuarial Transformation efforts, shedding light on their future prospects and emphasizing emerging Advanced Analytics techniques. The second report serves as the inaugural installment of a series dedicated to identifying promising innovations for underwriters and actuaries, and it promises to alert the SOA to the latest developments. During this session, our presenters will provide an insightful overview of the key findings and key takeaways from both research reports. By the end of the session, attendees will gain a deeper understanding and appreciation for the invaluable research conducted in these areas.

Description: Discuss issues related to illustrations, including illustration testing, ASOP 24, the illustration model regulation and AG 49 at the practice level. Come prepared with questions and comments on the world of illustrations and illustration testing. Explore ideas for what's working and not working in the illustration world and formulate plans to tackle pressing illustrations issues. At the end of this workshop, you will be able to Identify issues related to illustrations and illustration testing for life products, discuss possible ways to resolve issues issue identified, and explore the future state of illustrations and illustration testing for various products.

Description: Experts from both the direct and reinsurance side of the table will provide an overview of final expense products and their key features, as well as share experiences that have informed best practices when designing, selling, managing, monitoring and reinsuring these products. Trends in distribution, underwriting tools and other competitive factors will be considered through the lens of managing risk while remaining competitive in the market.

Description: At the conclusion of the first part, attendees will be able to describe sources of reserve redundancy for products under Principle Based Reserve (PBR) and products under Commissioners' Annuity Reserve Valuation Method (CARVM). Such products include Term Life, Whole Life, Universal Life, and Fixed Annuity with and without rider. We will also review sources of capital redundancy from the C-1 factor under Risk-Based Capital (RBC) and assets such as Unrated Asset Credit Fund can have high C-1 factor even if its risks are limited. At the conclusion of the second part, the attendees will learn about potential Reserve Relief reinsurance solutions. Such solutions can provide Reserve Relief for annuity and term life businesses, as well as potential innovative asset-side solutions. Asset managers can structure assets that the C-1 factor aligned with the corresponding risk.

Description: Mortality improvement for the U.S. general population has stagnated in recent years and then further deteriorated with the COVID-19 pandemic. However, mortality improvement by socioeconomic factors such as education and income has varied widely during this time period. Explore with us cause-of-death mortality rate trends as well as overall mortality improvement trends by different socioeconomic factors. Join a discussion on approaches that companies can take to proxy the insured population by applying socioeconomic factors to the general population with the goal of better understanding future mortality trends for the insured population.